- Butafosfan
-
- $0.00 / 1kg
-
2024-04-16
- CAS:17316-67-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- butaphosphan
-
- $0.00 / 1Kg
-
2024-04-09
- CAS:17316-67-5
- Min. Order: 1Kg
- Purity: 99.9%
- Supply Ability: 200tons
- Butaphosphan
-
- $0.00 / 1kg
-
2024-03-29
- CAS:17316-67-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
|
| Product Name: | Butafosfan | | Synonyms: | 1-(butylamino)-1-methylethyl]-phosphonic acid;BUTAFOSFAN;BUTAPHOSPHAN(BUTAFOSFAN);Phosphinic acid, 1-(butylamino)-1-methylethyl-;[1-Butylamino-1-methylethyl]phosphinic acid;Phosphinic acid,P-[1-(butylaMino)-1-Methylethyl]-;Butapho;Butafo | | CAS: | 17316-67-5 | | MF: | C7H18NO2P | | MW: | 179.2 | | EINECS: | 241-341-7 | | Product Categories: | API;Veterinary API;17316-67-5 | | Mol File: | 17316-67-5.mol |  |
| | Butafosfan Chemical Properties |
| Melting point | 219 °C | | Boiling point | 273.4±42.0 °C(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Methanol (Slightly), Water (Slightly) | | pka | 2.99±0.10(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic | | InChI | InChI=1S/C7H18NO2P/c1-4-5-6-8-7(2,3)11(9)10/h8,11H,4-6H2,1-3H3,(H,9,10) | | InChIKey | WCXWARPXYQCRPP-UHFFFAOYSA-N | | SMILES | P(C(NCCCC)(C)C)(O)=O | | CAS DataBase Reference | 17316-67-5(CAS DataBase Reference) |
| | Butafosfan Usage And Synthesis |
| Veterinary raw materials | Butafosfan is veterinary raw materials to promote metabolism with a strong antioxidant, which can effectively inhibit self-oxidation of fat at lower concentrations. In pure physical stimulation mode, it can enhance assimilation of each part in animal body, and can promote liver function, promote enhancement of smooth muscle function and improvement of skeletal muscle system in various organs, and help muscles movement and recovery from fatigue, reduce stress reaction, stimulate appetite, promote non-specific immune function.
Butafosfan, as main ingredient of organic phosphorus supplement, can participate in the citric acid cycle in vivo, promote metabolism, speed up synthesis and utilization of the body's essential energy, and therefore can enhance the body's non-specific immunity, improve disease resistance ability of the body, but also can effectively remove the body's metabolism of ketone bodies. improve the lactic acid content, help fast rehabilitation of the disease.
The above information is edited by the chemicalbook of Liu Yujie.
| | Clinical application | Compatibility of Butafosfan and vitamin B12 (abbreviation: VB12) has synergistic effect, VB12 is involved in various metabolism, such as carbohydrates, fat, participating in biosynthesis of essential amino acids and proteins, participating in synthesis of blood cells, playing an important role in the maintenance of normal nerve tissue and heart function, at the same time maintaining a normal gastrointestinal motility and gastric secretion and gastrointestinal absorption of fat and normal function of fermentation, promoting growth and feed efficiency of livestock. It adapts for disease prevention and health treatment in all stages of pigs, speeding up the rehabilitation of sick animals.
1.Effective rehabilitation and restoration of liver and kidney organ damage caused by "toxic mold" and "background disease ", it can promote detoxication and detoxification function of liver and kidney and play a role in protecting liver and kidney.
2.As for the prevention and treatment of various diseases in pigs, in particular, a number of diseases caused by immunosuppression, such as swine fever, blue ear disease, swine flu, pseudorabies, porcine circovirus disease, swine vesicular disease and pleural pneumonia, Vice pig addicted blood, etc. it has a good secondary effect. During disease infection with use of this product can accelerate the recovery.
3.It can relieve immunosuppression, strengthen non-specific immune function, activate the immune system, improve disease resistance and stress responses in pigs.
4. It can be used to improve metabolism of sick animals to promote their rehabilitation, making insulin concentration increase, improving appetite and feed intake of animals at the greatest extent.
5. It can improve the ability of lactating sows, shorten diestrus after weaning; improve the libido of boar and quality of semen.
6. Butafosfan can patch the sow metabolism dysfunction, promote smooth muscle function of uterine, make delivery faster and more smoothly, and help sow recover from fatigue in production, maintain feed intake and milk yield, avoid occurrence of reproductive failure. In piglets, it can improve their physical resistance by various stress experienced after the birth, so as to reduce the incidence of the disease, and can promote production of red blood cell, promote metabolism, accelerate the growth rate. | | Usage | Veterinary raw materials, main active ingredient of organic phosphorus supplement; promoting liver function; helping muscle co-op system recovery from fatigue; reducing stress reaction; stimulating the appetite; promoting non-specific immune function; simple physical stimulation pattern, no residue in vivo, no side effects. | | Chemical Properties | Butafosfan is a white crystalline powder, very easily is dissolved in water. soluble in organic solvents such as ethanol, which should be purged with an inert gas. The solubility of butafosfan in ethanol is approximately 1 mg/ml. It has the effect that improves energy metabolism and strengthen immunologic function. | | Uses | Butafosfan is an organic phosphorus supplement that is given, most commonly with cyanocobalamin, to cattle, swine, horses, and poultry for the prevention or treatment of deficiencies. When given with cyanocobalamin, butafosfan alters lipid metabolism, serving to decrease the prevalence of subclinical ketosis. | | benefits | Butafosfan works by increasing the body's ability to metabolise glucose and other nutrients, as well as supporting the production of adenosine triphosphate, which is the main source of cellular energy. Cyanocobalamin, a form of vitamin B12, is essential for normal nerve function and red blood cell formation. | | Mechanism of action | Butafosfan works by improving the body’s ability to metabolize glucose and other nutrients, as well as by supporting the production of ATP, which is the primary source of energy for cells. The association of Butafosfan and cyanocobalamin could favors the phosphorylation of molecules that intermediate metabolic pathways, such as a gluconeogenesis, glycolysis, and the Krebs cycle, improving the synthesis of the co-nutrients (ATP and ADP mainly) and consequently increasing blood glucose. However, it is still unclear if these results refer mainly to one of the nutrients, Butafosfan or cyanocobalamin[1].
| | Side effects | Common side effects may include indigestion, such as vomiting or diarrhoea, and local irritation at the injection site. In rare cases, more serious side effects, such as allergic reactions or neurological damage, may occur. | | Metabolism | In vitro metabolism studies in rat liver microsomes and hepatocytes revealed no metabolites of butafosfan using liquid chromatography-mass spectrometry (LC-MS) for the analysis. The intravenous administration of butafosfan to cattle at a dose level of 5.6 mg/kg bw as a singledose resulted in a pharmacokinetic profile in serum corresponding to a three-compartment model.Three half-lives were calculated to 1.7 minutes,13.2 minutes and 1.38 hours; the latter describingthe terminal elimination process. Urine is the major route of excretion of butafosfan and a meanof 74% and 0.2% of parent compound was recovered in urine and faeces respectively, within thefirst 12 hours. This study was not radiolabelled, but was conducted in accordance with GLPstandards and the analyses were performed with liquid chromatography-tandem massspectrometry (LC-MS/MS). | | Toxicity evaluation | The acute toxicity of butafosfan is very low. The oral LD50 in mice was approximately 16 000 mg/kg bw. After parenteral administrations, the following LD50 values were obtained in mice: approximately 21 000 mg/kg bw (subcutaneously), approximately 10 000 mg/kg bw (intravenously) and greater than 2500 mg/kg bw (intraperitoneally). Mice dosed orally or subcutaneously died within 3 and 2 days, respectively, while survivors had recovered by that time. The LD50 value in chicken (intramuscularly) was 9974 mg/kg bw. Observed toxic signs were excitation, cyanosis, sternal recumbency and diarrhoea. | | References | [1] Weiller M, et al. Butaphosphan Effects on Glucose Metabolism Involve Insulin Signaling and Depends on Nutritional Plan. Nutrients, 2020; 12: 1856. |
| | Butafosfan Preparation Products And Raw materials |
|